Last week, our amazing Medical Director Dr. Paul Kent was a special guest on an episode of TARGET: Cancer Podcast with Dr. Sanjay Juneja, the “OncDoc.”
In the discussion, Dr. Kent sheds light on the unique challenges faced by patients with fibrolamellar carcinoma and gives updates on recent successes in obtaining treatment approvals. They also discuss the DNAJB1-PRKACA mutation, treatment advancements, and the power of hope in facing this condition.
We want you to hear the hope this discussion offers and FibroFighter’s approach to helping our patients and families deal with a Fibrolamellar diagnosis. We ask for your financial and emotional support in helping us continue all our important patient-directed initiatives. We are making a difference one patient at a time.